Switch to
More onapp

Sun Pharmaceutical Industries Ltd

SUNPHARMA
Health CarePharmaceuticals
LargecapWith a market cap of ₹2,48,134 cr, stock is ranked 25
Low RiskStock is 1.33x as volatile as Nifty
1,046.053.80 (-0.36%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
LargecapWith a market cap of ₹2,48,134 cr, stock is ranked 25
Low RiskStock is 1.33x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
75.82
PB RatioPB Ratio
4.86
Dividend YieldDiv. Yield
0.97%
Sector PESector PE
35.90
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

89%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Sun Pharmaceutical Industries Limited is a specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a range of generic formulations. It produces a portfolio of generic and specialty medicines targeting a spectrum of chronic and acute treatments. The Company’s product portfolio includes generics, branded generics, specialty, over the counter (OTC)/consumer healthcare products, anti-retrovirals (ARVs), active pharmaceutical ingredients (APIs) and intermediates. Its OTC brands includes Faringosept , Revital, and Volini. The Company offers its products in variety of dosage forms, such as tablets, capsules, sprays, injectables, inhalers, ointments, creams and liquids. Its portfolio of specialty products, branded generics are available across 100 countries. The Company operates manufacturing sites across 6 continents.

Brands

Revital

Health & vitamin supplement

Volini

Pain reliving spray

Investor PresentationView older 

Sep 16, 2022

PDF
View Older Presentations

Brands

Revital

Health & vitamin supplement

Volini

Pain reliving spray

Financial TrendFinancial statements 

201920202021202230.0933.4934.3639.732.673.762.903.27
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss of share certificate 
Announced OnNov 22, 2022

Sun Pharmaceutical Industries Limited has informed the Exchange about issue of duplicate certificate | Download

Sun Pharmaceutical Industries Limited has informed the Exchange about issue of duplicate certificate | Download

Loss of share certificate 
Announced OnNov 22, 2022

Sun Pharmaceutical Industries Limited has informed the Exchange about Loss of share certificate | Download

Sun Pharmaceutical Industries Limited has informed the Exchange about Loss of share certificate | Download

Cash Dividend 
Ex. DateAug 19, 2022

Final • Div/Share: ₹ 3

See all events